The Promise of AI in Life Sciences and Healthcare

Artificial intelligence is all around us and it's revolutionizing our world in many ways. In life sciences and healthcare, AI-powered technologies are instrumental in tasks such as diagnostics, precision medicine and even robotic surgery. And the transformative aspect of generative AI is already being felt in areas such as pharmaceutical research, epidemiology and telemedicine. There are projections that the global market for AI in life sciences and healthcare will be $6.7 billion USD by 2030 . What is driving such remarkable growth and how rosy is this picture? Joining us at the start of a new season three of the "Ideas to Innovation" podcast from Clarivate is Henry Levy , who has plenty to say about AI and what it will and won't enable us to achieve. Henry joined Clarivate earlier this year as President, Life Sciences and Healthcare (LS&H). He leads the teams focused on developing solutions that enable life sciences and healthcare companies and providers to create a healthier tomorrow by connecting them to transformative intelligence and data technology to improve patient lives. With more than 25 years of experience, Henry is the author of multiple articles on drug development and tech trends and a frequent speaker at industry forums. He holds a bachelor's degree in bioengineering from the University of Pennsylvania .

You can listen to The Promise of AI in Life Sciences and Healthcare online on Radio and Podcast. Open the player on this page to stream the available audio.

The Promise of AI in Life Sciences and Healthcare is an episode from Ideas to Innovation by Clarivate.

This episode is 24:09 long.

This episode was published on Sep 14, 2023.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Ideas to Innovation when more episodes are available from the podcast feed.